Respiratory & Pulmonology

2+ hour, 43+ min ago   (78+ words) tradingview.com A major strategic shift is underway, expanding from orphan pulmonary hypertension to large pulmonary fibrosis and COPD markets, with multiple new products and formulations in late-stage development. Revenue is projected to grow significantly, supported by robust clinical data,…...

9+ hour, 22+ min ago   (515+ words) Managing Editor Michael P. Barbella has worked as a journalist for nearly 25 years, reporting for newspapers, television and trade magazines. He began his career chronicling North Jersey politics, education, business and lifestyle for two daily newspapers before lending his skills to…...

2+ hour, 43+ min ago   (657+ words) Children aged 2 to 5 with cystic fibrosis who switched from Trikafta to the newer once-daily drug Alyftrek saw their sweat chloride levels fall further, with about two-thirds reaching the range considered normal. Vertex Pharmaceuticals presented the data as a late-breaking abstract…...

11+ hour, 1+ min ago   (92+ words) Frost & Sullivan commends SleepRes for setting a high standard in product innovation, clinical integration, and patient-centric design within the Positive Airway Pressure Devices industry. The company’s vision, supported by FDA 510(k) clearance and a strong clinical foundation, is shaping the…...

6+ hour ago   (688+ words) Inhaled therapy Mosliciguat now being tested in a Phase 3 clinical trial Written by Margarida Maia, PhD | Sept. 14, 2026 Mosliciguat, an inhaled treatment being developed by Pulmovant, was well tolerated and more effective than a placebo at improving blood flow through the…...

7+ hour, 1+ min ago   (13+ words) The Brussels Times...

5+ hour ago   (238+ words) Mon Sep 14, 2026 September 14, 2026 9:06 PM GMT+1 Tokyo is set to host an unusual competition in which participants will compete to achieve the best sleep quality rather than physical or mental performance. The event, scheduled for October 5, 2026, will see contestants sleep for…...

9+ hour, 21+ min ago   (54+ words) Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit Overcoming the Challenge of Maintaining Weight Reduction Sympathetic Overactivity: The Driver of Hypertension in Young Indians India's Medical Startups: From Innovation to Impact - Prof. (Dr) Yogendra Kumar…...

19+ hour, 6+ min ago   (493+ words) Frost & Sullivan is pleased to announce that SleepRes has been recognized with the 2026 North America New Product Innovation Recognition in the Positive Airway Pressure Devices industry for its outstanding achievements in product innovation, clinical differentiation, and patient-centric therapy design. This…...

2+ hour, 19+ min ago   (104+ words) A new report reveals the 100 most challenging U.S. cities for living with asthma just as the nation heads into its September asthma peak. Kenneth Mendez, president and CEO of AAFA, and Dr. Mitch Grayson, asthma specialist and chair of AAFA's Medical…...